To elucidate the potential molecular mechanisms underlying SAC3D1’s oncogenic role in HCC, pathway enrichment analysis revealed its involvement in activating the PI3K/Akt signaling pathway in HCC cell lines. The gene discussed is AKT1; the disease is hepatocellular carcinoma.